Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
2015
Pharmacokinetics and Pharmacodynamics of Edivoxetine (LY2216684), a Norepinephrine Reuptake Inhibitor, in Pediatric Patients with Attention-Deficit/ Hyperactivity Disorder
2012
Pharmacokinetics of Afatinib, a Selective Irreversible ErbB Family Blocker, in Patients with Advanced Solid Tumours
2013
Lipid lowering with PCSK9 inhibitors
2014
Effects of Hemodialyzer Reuse on Clearances of Urea and β2-Microglobulin
1999
Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers
2010
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
2017
The FGF family: biology, pathophysiology and therapy
2009 Standout
Intracerebral haemorrhage
2009 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Targeting PCSK9 for Therapeutic Gains
2015
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
2015
Natural products: A continuing source of novel drug leads
2013 Standout
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
2013
Cholesterol-lowering effects of dietary fiber: a meta-analysis
1999 Standout
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
2015
Intraventricular hemorrhage treated with intraventricular fibrinolysis. A 10-year experience
2012
Mortality Risk by Hemodialyzer Reuse Practice and Dialyzer Membrane Characteristics: Results From the USRDS Dialysis Morbidity and Mortality Study
2001
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks
2012
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder
2012
The Effect of Palifermin on Chemotherapyand Radiation Therapy–Induced Mucositis: A Review of the Current Literature
2007
A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorder
2014
Application of iridium catalyzed allylic substitution reactions in the synthesis of branched tryptamines and homologues via tandem hydroformylation–Fischer indole synthesis
2008
QT Correction Methods in Children and Adolescents
2005
Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
2013
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
Clinical Pharmacokinetics of Ibuprofen
1998
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Non-viral vectors for gene-based therapy
2014 Standout
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
Intraventricular thrombolysis with rt-PA in patients with intraventricular hemorrhage
2011
Targeting apoptosis in cancer therapy
2020 Standout
The use of intraventricular thrombolytics in intraventricular hemorrhage
2007
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
2002 Standout
Intra-abdominal packing with laparotomy pads and QuikClot™ during damage control laparotomy: A safety analysis
2016
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Phosphoramidites: Privileged Ligands in Asymmetric Catalysis
2010 StandoutNobel
Atherosclerosis
2019 Standout
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
2016
Influence of intraventricular fibrinolytic therapy with rt‐PA on the long‐term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case–control study
2008
Toll‐like receptor 4 contributes to poor outcome after intracerebral hemorrhage
2011 StandoutNobel
Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors
2008
The Severe Hypercholesterolemia Phenotype
2014
DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer
2014
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Accelerated Death Rate in Population-Based Cohort of Persons With Traumatic Brain Injury
2013
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
1991 Standout
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Complications of intracerebral haemorrhage
2011
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Machine learning for data-driven discovery in solid Earth geoscience
2019 StandoutScience
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
Intraventricular hemorrhage
2008
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Estimating the global incidence of traumatic brain injury
2018 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Targeting PCSK9 for Hypercholesterolemia
2013
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Metabolism-guided drug design
2012
Researching the Links between School Resources and Student Outcomes in the UK: A Review of Issues and Evidence
2002
Similarity of Bisphenol A Pharmacokinetics in Rhesus Monkeys and Mice: Relevance for Human Exposure
2010
Pharmacokinetics of Nikkomycin Z after Single Rising Oral Doses
2009
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome
2016
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
1989 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Teachers, Schools, and Academic Achievement
2005 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
P450-catalyzed asymmetric cyclopropanation of electron-deficient olefins under aerobic conditions
2014 StandoutNobel
Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis
2019
NADPH-Dependent Covalent Binding of [3H]Paroxetine to Human Liver Microsomes and S-9 Fractions: Identification of an Electrophilic Quinone Metabolite of Paroxetine
2007
The effect of diet on plasma lipids, lipoproteins, and coronary heart disease
1988
Toward the Geoscience Paper of the Future: Best practices for documenting and sharing research from data to software to provenance
2016
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
2014
Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with the soybean protein diet
1982
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009 Standout
High density lipoprotein metabolism.
1984
Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
2008
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Brian P. Smith being referenced
Epigenetic Differences in Normal Colon Mucosa of Cancer Patients Suggest Altered Dietary Metabolic Pathways
2012
Must try harder
1988
Atomoxetine Pharmacokinetics in Children and Adolescents with Attention Deficit Hyperactivity Disorder
2003
CHRONOBIOTIC EFFECTS OF THE MELATONIN AGONIST LY 156735 FOLLOWING A SIMULATED 9H TIME SHIFT: RESULTS OF A PLACEBO-CONTROLLED TRIAL
2002
Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab
2010
Effect of Renal Function on the Pharmacokinetics of Palifermin
2006
Intraventricular Administration of rt-PA in Patients with Intraventricular Hemorrhage
2005
Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels
2012
“SCIP”ping antibiotic prophylaxis guidelines in trauma
2012
Skin closure after trauma laparotomy in high-risk patients
2013
THE ANALGESIC INTERACTION OF MISOPROSTOL WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
1996
Confidence Interval Criteria for Assessment of Dose Proportionality
2000
Do Chronic Liver Disease Scoring Systems Predict Outcomes in Trauma Patients With Liver Disease? A Comparison of MELD and CTP
2010
Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine Pharmacokinetics
2002
Maintaining blood compartment volume in dialyzers reprocessed with peracetic acid maintains Kt/V but not β2-microglobulin removal
1997
Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor
2015
Analysis of The QT Interval in Clinical Trials
2002
EFFECTS OF EVOLOCUMAB ON LIPOPROTEIN PARTICLES AND SUBCLASSES IN HYPERCHOLESTEROLEMIC AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS ON STATIN THERAPY
2014
Low density and high density lipoprotein kinetics and sterol balance in vegetarians
1981
Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine
2017
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites
2003